Friday 6 November 2026 Export VCYT’s income statement to Excel — free account

Veracyte, Inc.

VCYT Healthcare Diagnostics & Research

Veracyte, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $517.1 million, up 16.0% from fiscal 2024.

Revenue: +15.1%
EPS: +62.5%
Free cash flow: −9.63%

Quarter to September 2026, against a year earlier

24.18 0.18 +0.75%

Follow VCYT

Alert me

Market cap: $1.9B
P/E: 15.2×
Fwd P/E: 45.2×
Dividend yield: —
F-score: 8/9
Altman Z: 21.08
Beneish M: −2.66
Dividend safety: n/a

Overview

Veracyte, Inc. (VCYT) Debt to equity

Alert me on Debt to equity

Veracyte, Inc.'s debt to equity at the end of the quarter to 30 September 2026 was 0.0×, down 0.0× from fiscal 2025 (0.0×). Over the past ten years it has ranged from 0.0× (fiscal 2025) to 0.7× (fiscal 2017) — the current reading is the lowest in ten years. That is below the Diagnostics & Research industry median of 0.0× and in line with the Healthcare sector median of 0.0×.

Embed this chart

Code for your page

<iframe src="https://stockrow.com/embed/VCYT/debt-to-equity" width="100%" height="360" style="border:0" loading="lazy" title="Veracyte, Inc. debt to equity, 10 years"></iframe>
<p style="font-size:12px">Source: <a href="https://stockrow.com/VCYT/metrics/debt-to-equity">Veracyte, Inc. (VCYT) debt to equity — stockrow.com</a></p>

Period	Debt to equity	Change
FY2025	0.0×	—
FY2024	0.0×	—
FY2023	0.0×	—
FY2022	0.0×	—
FY2021	0.0×	(85.07%)
FY2020	0.0×	(5.63%)
FY2019	0.0×	(97.76%)
FY2018	0.3×	(53.26%)
FY2017	0.7×	58.35%
FY2016	0.4×	339.73%

Period	Debt to equity	Change
Sep 2026	0.0×	—
Jun 2026	0.0×	—
Mar 2026	0.0×	—
Dec 2025	0.0×	—
43 more quarters	Free account

Against its own ten years

Low 0.0× High 0.7×

Ten-year median 0.0×

Current reading's percentile 36

Company	Debt to equity
VCYT Veracyte, Inc.	0.0×
CDNA CareDx, Inc. compare	0.0×
GRAL GRAIL, Inc. compare	0.0×
BLLN BillionToOne, Inc. compare	0.0×
ADPT Adaptive Biotechnologies Corporation compare	0.0×
WGS GeneDx Holdings Corp. compare	0.4×
NEO NeoGenomics, Inc. compare	0.5×
RDNT RadNet, Inc. compare	0.9×
SHC Sotera Health Company compare	3.1×
Diagnostics & Research industry median	0.0×
Healthcare sector median	0.0×
Market median	0.1×

What Debt to equity is

Debt to Equity Ratio shows how much a company relies on borrowed money compared with the money its shareholders have in the business.

(Long Term Debt (Total) + Current Part of Debt) ÷ Shareholders Equity (Total)

The full definition of Debt to equity →

Veracyte, Inc. (VCYT) Debt to equity

Debt to equity, annual

Annual newest first

Quarterly newest first

Against its own ten years

Debt to equity against peers

What Debt to equity is

More on VCYT

Debt to equity, annual

Annual newest first

Quarterly newest first

Against its own ten years

Debt to equity against peers

What Debt to equity is

More on VCYT

Stockrow Weekly